Exodus Point Capital Management, LP Veru Inc. Transaction History

Exodus Point Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.55 - $6.41 $132,036 - $186,011	-29,019 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$5.89 - $9.73 $29,208 - $48,251	-4,959 Reduced 14.59%	29,019 $171,000
Q3 2021 Nov 15, 2021	SELL	$6.78 - $9.89 $243,347 - $354,971	-35,892 Reduced 51.37%	33,978 $290,000
Q2 2021 Aug 16, 2021	SELL	$7.24 - $11.2 $105,168 - $162,691	-14,526 Reduced 17.21%	69,870 $564,000
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $679,387 - $1.75 Million	84,396 New	84,396 $909,000

Q2 2020 Aug 14, 2020	SELL	$3.01 - $4.02 $70,735 - $94,469	-23,500 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.58 - $4.58 $405,325 - $719,531	-157,103 Reduced 86.99%	23,500 $77,000
Q4 2019 Feb 14, 2020	BUY	$1.86 - $3.35 $290,723 - $523,615	156,303 Added 643.22%	180,603 $605,000
Q3 2019 Nov 14, 2019	BUY	$1.81 - $2.36 $43,983 - $57,348	24,300 New	24,300 $52,000

104

44M

519K

396K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $76.1M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.